-
Creative Biolabs strives to transition iPSC technology into safe, effective and consistent therapies for various diseases and cancers effecting populations worldwide. Based on our extensive experience, now we can provide the teratoma formation assays to characterize the pluripotency of iPSCs for our customers all over the world.
-
Category
Research -
Created
Thursday, 09 January 2025 -
Group admin
cailynn johnson
My Portfolio
Close X